Literature DB >> 19700765

Metabolic adaptations to interrupted glycosaminoglycan recycling.

Josh C Woloszynek1, Atilla Kovacs, Kevin K Ohlemiller, Marie Roberts, Mark S Sands.   

Abstract

Lysosomal storage diseases (LSD) are metabolic disorders characterized by accumulation of undegraded material. The mucopolysaccharidoses (MPS) are LSDs defined by the storage of glycosaminoglycans. Previously, we hypothesized that cells affected with LSD have increased energy expenditure for biosynthesis because of deficiencies of raw materials sequestered within the lysosome. Thus, LSDs can be characterized as diseases of deficiency as well as overabundance (lysosomal storage). In this study, metabolite analysis identified deficiencies in simple sugars, nucleotides, and lipids in the livers of MPSI mice. In contrast, most amino acids, amino acid derivatives, dipeptides, and urea were elevated. These data suggest that protein catabolism, perhaps because of increased autophagy, is at least partially fulfilling intermediary metabolism. Thus, maintaining glycosaminoglycan synthesis in the absence of recycled precursors results in major shifts in the energy utilization of the cells. A high fat diet increased simple sugars and some fats and lowered the apparent protein catabolism. Interestingly, autophagy, which is increased in several LSDs, is responsive to dietary intervention and is reduced in MPSVII and MPSI mice fed a high fat diet. Although long term dietary treatment improved body weight in MPSVII mice, it failed to improve life span or retinal function. In addition, the ventricular hypertrophy and proximal aorta dilation observed in MPSVII mice were unchanged by a high fat, simple sugar diet. As the mechanism of this energy imbalance is better understood, a more targeted nutrient approach may yet prove beneficial as an adjunct therapy to traditional approaches.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700765      PMCID: PMC2785600          DOI: 10.1074/jbc.M109.020818

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Retinal function is improved in a murine model of a lysosomal storage disease following bone marrow transplantation.

Authors:  K K Ohlemiller; C A Vogler; M Roberts; N Galvin; M S Sands
Journal:  Exp Eye Res       Date:  2000-11       Impact factor: 3.467

Review 2.  Glucose transport in brain and retina: implications in the management and complications of diabetes.

Authors:  A K Kumagai
Journal:  Diabetes Metab Res Rev       Date:  1999 Jul-Aug       Impact factor: 4.876

Review 3.  Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential.

Authors:  Charles R Roe; Fanny Mochel
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

4.  Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease).

Authors:  Masato Koike; Masahiro Shibata; Satoshi Waguri; Kentaro Yoshimura; Isei Tanida; Eiki Kominami; Takahiro Gotow; Christoph Peters; Kurt von Figura; Noboru Mizushima; Paul Saftig; Yasuo Uchiyama
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

5.  Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells.

Authors:  Kartik Venkatachalam; A Ashleigh Long; Rebecca Elsaesser; Daria Nikolaeva; Kendal Broadie; Craig Montell
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

6.  Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.

Authors:  Bhuvarahamurthy Venugopal; Marsha F Browning; Cyntia Curcio-Morelli; Andrea Varro; Norman Michaud; Nanda Nanthakumar; Steven U Walkley; James Pickel; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

7.  Lysosomal dysfunction results in altered energy balance.

Authors:  Josh C Woloszynek; Trey Coleman; Clay F Semenkovich; Mark S Sands
Journal:  J Biol Chem       Date:  2007-10-02       Impact factor: 5.157

8.  Chaperone-mediated autophagy is defective in mucolipidosis type IV.

Authors:  Bhuvarahamurthy Venugopal; Nicholas T Mesires; John C Kennedy; Cyntia Curcio-Morelli; Janice M Laplante; J Fred Dice; Susan A Slaugenhaupt
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

9.  Lysosomal degradation of glycoproteins and glycosaminoglycans. Efflux and recycling of sulphate and N-acetylhexosamines.

Authors:  L H Rome; D F Hill
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

10.  Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B.

Authors:  Coy D Heldermon; Anne K Hennig; Kevin K Ohlemiller; Judith M Ogilvie; Erik D Herzog; Annalisa Breidenbach; Carole Vogler; David F Wozniak; Mark S Sands
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

View more
  18 in total

1.  Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.

Authors:  Guilherme Baldo; Susan Wu; Ruth A Howe; Meera Ramamoothy; Russell H Knutsen; Jiali Fang; Robert P Mecham; Yuli Liu; Xiaobo Wu; John P Atkinson; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2011-08-24       Impact factor: 4.797

Review 2.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

Review 3.  Specific sides to multifaceted glycosaminoglycans are observed in embryonic development.

Authors:  Kenneth L Kramer
Journal:  Semin Cell Dev Biol       Date:  2010-07-03       Impact factor: 7.727

4.  Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.

Authors:  Haiyan Fu; Aaron S Meadows; Tierra Ware; Robert P Mohney; Douglas M McCarty
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

5.  Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease.

Authors:  Li Ou; Michael J Przybilla; Chester B Whitley
Journal:  Mol Genet Metab       Date:  2018-09-14       Impact factor: 4.797

6.  Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Kim M Hemsley; John J Hopwood
Journal:  J Inherit Metab Dis       Date:  2010-05-07       Impact factor: 4.982

7.  Improved efficacy of a next-generation ERT in murine Pompe disease.

Authors:  Su Xu; Yi Lun; Michelle Frascella; Anadina Garcia; Rebecca Soska; Anju Nair; Abdul S Ponery; Adriane Schilling; Jessie Feng; Steven Tuske; Maria Cecilia Della Valle; José A Martina; Evelyn Ralston; Russell Gotschall; Kenneth J Valenzano; Rosa Puertollano; Hung V Do; Nina Raben; Richie Khanna
Journal:  JCI Insight       Date:  2019-03-07

Review 8.  Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?

Authors:  Jacqueline A Hawkins-Salsbury; Adarsh S Reddy; Mark S Sands
Journal:  Hum Mol Genet       Date:  2011-03-19       Impact factor: 6.150

9.  Simple nutrients bypass the requirement for HLH-30 in coupling lysosomal nutrient sensing to survival.

Authors:  John T Murphy; Haiyan Liu; Xiucui Ma; Alex Shaver; Brian M Egan; Clara Oh; Alexander Boyko; Travis Mazer; Samuel Ang; Rohan Khopkar; Ali Javaheri; Sandeep Kumar; Xuntian Jiang; Daniel Ory; Kartik Mani; Scot J Matkovich; Kerry Kornfeld; Abhinav Diwan
Journal:  PLoS Biol       Date:  2019-05-14       Impact factor: 8.029

10.  Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.

Authors:  Jason A Metcalf; Bruce Linders; Susan Wu; Paul Bigg; Patricia O'Donnell; Meg M Sleeper; Michael P Whyte; Mark Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.